-
Mashup Score: 7How to best convey continuous outcomes in patient decision aids - 16 hour(s) ago
The work of transforming scientific publications into tools that can support people in comparing treatments, tests and other interventions has been driven by efforts to support shared decision-making. The International Patient Decision Aids Standards (IPDAS) Collaboration has published many articles that guide this process. IPDAS, and others in this field, have considered the challenges of representing complex concepts such as effect sizes, ORs and relative risk rates in terms and formats that are easier to understand by people with varying levels of health literacy and numeracy. The underlying task is how to simplify research results without misleading people, which is essential when communicating healthcare information. Selecting outcome probabilities and comparing data collected from different populations with various study designs would be misleading. Further, only providing relative instead of absolute risk estimates would lead to misinterpretation in most situations, framing that
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4
Clinical practice guidelines (CPGs) are ‘systematically developed statements to assist practitioner and patient decisions about appropriate healthcare for specific circumstances’.1 The implementation of guidelines can help optimise resource utilisation, reduce variations in clinical practice and identify and apply evidence-based recommendations safely and effectively.2 In China, the number of guidelines is increasing annually, while low adherence remains a significant challenge. Low adherence not only wastes healthcare resources but also allows preventable deaths to occur. Addressing the poor implementation of guidelines in China is urgent. Implementation research, which is the scientific study to promote evidence-based practices into routine practice,3 may be feasible to improve guideline adherence. For example, by finding the barriers and facilitators for the guideline implementation, the implementation strategy is designed accordingly. However, in China, which has a large population
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
Overcoming challenges in the implementation of clinical practice guidelines in China #Analysis Link: https://t.co/a2u9NhmzXq https://t.co/kRVWmYnStc
-
-
Mashup Score: 33Developing guideline recommendations about tests: educational examples of test-management pathways - 1 month(s) ago
Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on h
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/T2hY9EMYfs https://t.co/6i9iBqzi46
-
-
Mashup Score: 33Developing guideline recommendations about tests: educational examples of test-management pathways - 1 month(s) ago
Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on h
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/T2hY9EMYfs https://t.co/6i9iBqzi46
-
-
Mashup Score: 33Developing guideline recommendations about tests: educational examples of test-management pathways - 1 month(s) ago
Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on h
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/T2hY9EMYfs https://t.co/6i9iBqzi46
-
-
Mashup Score: 33Developing guideline recommendations about tests: educational examples of test-management pathways - 1 month(s) ago
Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on h
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/T2hY9EMYfs https://t.co/6i9iBqzi46
-
-
Mashup Score: 33Developing guideline recommendations about tests: educational examples of test-management pathways - 2 month(s) ago
Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on h
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/T2hY9EMYfs https://t.co/6i9iBqzi46
-
-
Mashup Score: 33Developing guideline recommendations about tests: educational examples of test-management pathways - 2 month(s) ago
Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on h
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/T2hY9EMYfs https://t.co/6i9iBqzi46
-
-
Mashup Score: 31Developing guideline recommendations about tests: educational examples of test-management pathways - 2 month(s) ago
Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on h
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/T2hY9EMYfs https://t.co/6i9iBqzi46
-
-
Mashup Score: 27Developing guideline recommendations about tests: educational examples of test-management pathways - 2 month(s) ago
Recommendations about healthcare related testing in guidelines are common. Tests can be used for several purposes: screening, surveillance, risk classification, diagnosis, staging, treatment triage, determination of prognosis and monitoring/follow-up.1 The development of testing recommendations in guidelines is challenging, especially because the benefit of a test not only depends on test characteristics, such as sensitivity and specificity, but also on population characteristics and test consequences, such as management.2–4 Furthermore, the role of a new test in comparison to the existing testing scenario should be defined, since this influences the interpretation of the new test’s value. The following roles of new tests have been identified in the literature: triage, replacement, add-on, and parallel/combined.5 As with treatment, testing can have negative consequences, including physical impairment, psychological distress, disease labelling, and costs.6 There is limited evidence on h
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/T2hY9EMYfs https://t.co/6i9iBqzi46
-
How to best convey continuous outcomes in patient decision aids #Analysis by @glynelwyn et al. Link: https://t.co/VroKozUSOc https://t.co/p75ldWo0we